Researchers from the University of Queensland and Florey Institute of Neuroscience and Mental Health have discovered the potential for spider venom to be used to treat a form of childhood epilepsy.
Dravet Syndrome is a form of epilepsy which is caused by defects in the SCN1A gene, which can be targeted by the peptide in spider venom.
One in 500 children with epilepsy are likely to have Dravet Syndrome.